Tag: SkinDisease

Research on Necroptosis Inhibition: Novel Therapeutics for Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Japanese researchers uncover a key cell death pathway in SJS/TEN and develop FPR1 inhibitors that prevent necroptosis in model cells and mice, offering a potential breakthrough therapy for severe cutaneous adverse reactions.